Categories: NewsVaccine

Advanced Biological Research Group to Study Effects of mRNA on Women’s Reproduction

JACKSONVILLE, Fla., June 5, 2025 /PRNewswire/ — Advanced Biological Research Group (ABRG), a 501c3, has announced its second study to determine the effects of mRNA on women’s reproductive systems. The group’s 2024 pilot study focused on abnormal vaginal bleeding after exposure to mRNA and also the impact of mRNA shedding.

The new 2025 study will investigate the causes of the decrease in ovarian egg reserve and the overall decline in female fertility, as reported by a growing number of OB/GYNs globally.

The ABRG team includes founding members Kimberly Biss, MD, Kirstin Cosgrove BM, CCRA, Ryan Cole, MD, Dan McDyer, MD, noted specialist in maternal-fetal medicine, James A. Thorp, MD. and Dr. Steven J. Hatfill Emeritus, who now serves as Senior Adviser to the Secretary of Health and Human Services (HHS).

Dr. Thorp recently testified in front of the Senate Permanent Sub-Committee on Investigations (Senator Ron Johnson, WI [Chairman]; Senator Richard Blumenthal, CT [Ranking Member]) on the issue of mRNA vaccine adverse effects in the most vulnerable patients: pregnant woman, the unborn and newborn children. Members Dr. Biss and Dr. Cole had testified previously on several topics, including adverse effects in reproduction and the mRNA platform.

For information on supporting ABRG and its studies, please contact:
396338@email4pr.com or visit abrg.org.

Please direct all media inquiries to RECURSION MEDIA GROUP Inc. 396338@email4pr.com or 352-282-0778, or visit recursionmediagroup.com.

Recursion Media Group, Inc. (RMG) owns and operates Recursion Publishing, RMG Innovations, Recursion.Live, and RMG News Daily. For more information, please visit recursionmediagroup.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/advanced-biological-research-group-to-study-effects-of-mrna-on-womens-reproduction-302474686.html

SOURCE Advanced Biological Research Group

Staff

Recent Posts

Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed

GALWAY, Ireland, Dec. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in…

12 hours ago

Pinealage: the app that turns strangers into meditation companions — in crowdfunding phase

This app will connect people with strangers to meditate together in the real world—an invitation…

12 hours ago

IMG Saxony-Anhalt: 2026 in Sight – Saxony-Anhalt Sets the Pace for Future Industries

Despite challenging framework conditions such as high energy prices, the international introduction of tariffs, and…

12 hours ago

Kirby Medical Center Partners with Switchboard, MD to Automate Patient Communication Workflows

ATLANTA, Dec. 19, 2025 /PRNewswire/ -- Switchboard, MD is proud to announce a new enterprise partnership with…

12 hours ago

SIERRA7 RECOGNIZED AS A 2026 ELEV8 GOVCON AWARD WINNER

MCLEAN, Va., Dec. 19, 2025 /PRNewswire/ -- Sierra7, a leader in government healthcare and technology solutions,…

12 hours ago

Medome Launch Heralds the End of Medical Misdiagnoses and Lost Lives

NEW YORK, Dec. 19, 2025 /PRNewswire/ -- Medome is the first AI technology for Personal Health…

12 hours ago